---
title: "Accuray Incorporated (ARAY.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ARAY.US.md"
symbol: "ARAY.US"
name: "Accuray Incorporated"
industry: "Health Care Equipment"
datetime: "2026-05-21T13:43:10.885Z"
locales:
  - [en](https://longbridge.com/en/quote/ARAY.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ARAY.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ARAY.US.md)
---

# Accuray Incorporated (ARAY.US)

## Company Overview

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.accuray.com](https://www.accuray.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:16.000Z

**Overall: D (0.69)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 143 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -7.88% |  |
| Net Profit YoY | -6954.38% |  |
| P/B Ratio | 0.95 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 39579221.66 |  |
| Revenue | 428571000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -101.06% | E |
| Profit Margin | -10.76% | D |
| Gross Margin | 24.13% | C |
| Revenue YoY | -7.88% | D |
| Net Profit YoY | -6954.38% | E |
| Total Assets YoY | -7.58% | E |
| Net Assets YoY | -15.88% | E |
| Cash Flow Margin | 41.44% | C |
| OCF YoY | -7.88% | D |
| Turnover | 0.92 | A |
| Gearing Ratio | 90.68% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Accuray Incorporated",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-7.88%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-6954.38%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.95",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "39579221.66",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "428571000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-101.06%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-10.76%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "24.13%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-7.88%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-6954.38%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-7.58%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-15.88%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "41.44%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-7.88%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.92",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "90.68%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.86 | 82/183 | 232.66 | 212.76 | 200.52 |
| PB | 0.95 | 25/183 | 2.60 | 1.92 | 1.09 |
| PS (TTM) | 0.09 | 5/183 | 0.36 | 0.27 | 0.13 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T04:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 2 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.31 |
| Highest Target | 3.05 |
| Lowest Target | 2.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ARAY.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ARAY.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ARAY.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ARAY.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**